Ankylosing spondylitis, HLA-B27 positivity and the need for biologic therapies

ANKYLOSING SPONDYLITIS AND HL-A 27

D. A. Brewerton, F. Dudley Hart, Anne Nicholls et al. · The Lancet · 1973 · 1.9K citations

Medicine, Pathobiology, Inflammation +6

Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis

Ernst Feldtkeller, Muhammad A. Khan, Désirée van der Heijde et al. · Rheumatology International · 2003 · 869 citations

Life Sciences, Clinical Sciences, Immunology +10

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis

Martín Rudwaleit · Annals of the Rheumatic Diseases · 2004 · 438 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study).

Bjørn Moum, Aksel Ongre, Jan Tore Gran · PubMed · 2002 · 208 citations

Veterinary Medicine, Immunology, Immunopathology +5

The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease

Nuran Türkçapar, Murat Törüner, İrfan Soykan et al. · Rheumatology International · 2005 · 186 citations

Medicine, Immunology, Internal Medicine +16